201
A First-in-human Study to Investigate the Safety, Tolerability and Pharmacokinetics of MAS825 in Healthy Volunteers
Condition(s):Healthy VolunteersLast Updated:September 30, 2022Completed
First in Human: 7227 Clinical Trials, Page 21 of 723
Hide Studies Not Open or Pending
202
First in Human Study to Evaluate the Safety, Tolerability of HH30134 in Advanced Solid Tumors
Condition(s):Advanced Solid TumorsLast Updated:December 29, 2022Recruiting
203
A Two -Stage First in Human (FIH) Feasibility / Pivotal Study of the Vienna Aortic Valve SE System
Condition(s):Symptomatic Aortic StenosisLast Updated:September 28, 2022Recruiting
204
First in Human Study of NVG-111 in Chronic Lymphocytic Leukaemia and Mantle Cell Lymphoma
Condition(s):Chronic Lymphocytic Leukaemia; Small Lymphocytic Lymphoma; Mantle Cell LymphomaLast Updated:September 30, 2022Recruiting
205
First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy
Condition(s):Amyloid Transthyretin CardiomyopathyLast Updated:June 14, 2022Recruiting
206
First-in-human Trial With Single-dose C5a-neutralizing AON-D21 in Healthy Male Subjects
Condition(s):HealthyLast Updated:January 12, 2022Completed
207
First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects
Condition(s):Safety Issues; Tolerance; Idiopathic Pulmonary Fibrosis; Pulmonary HypertensionLast Updated:June 22, 2022Recruiting
208
The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies
Condition(s):Metastatic Solid Tumor; Lymphoma; Myeloproliferative Neoplasms (MPN)Last Updated:June 10, 2022Active, not recruiting
209
Phase Ib First in Human Dose Escalation of GT103 in Refractory, Advanced Stage Non-Small Cell Lung Cancer (TOP 1902)
Condition(s):Non-small Cell Lung CancerLast Updated:November 25, 2022Recruiting
210
First in Human Study to Assess Safety of VIS649 in Healthy Subjects
Condition(s):Immunoglobulin A Nephropathy; IgAN – IgA Nephropathy; IgA NephropathyLast Updated:March 6, 2020Completed